Category: Diabetes

The Confusing Fate of the Abortion Pill

The legality and availability of the abortion pill mifepristone is in question after a federal judge in Texas canceled the FDA’s approval of the first drug used in the two-drug medication abortion regimen. A 5th Circuit Court of Appeals panel overruled that decision in part, saying the pill should remain available, but only under the onerous restrictions in place before 2016. Meanwhile, another federal judge in Washington state issued a ruling in a separate case that conflicts with the Texas decision, ordering the FDA not to roll back any of its restrictions on the drug. Victoria Knight of Axios, Shefali Luthra of The 19th, and Sarah Karlin-Smith of the Pink Sheet join KFF Health News chief Washington correspondent Julie Rovner to discuss these issues and more.

Montana May Require Insurers to Cover Monitoring Devices for Diabetes

Montana is one of several states considering expanding coverage of continuous glucose monitors, but insurance companies and some providers argue that not all people with diabetes need them.

Breaking the stigma: Using life coaching to navigate chronic disease [PODCAST]

Subscribe to The Podcast by KevinMD. Catch up on old episodes! Join us with guest Kimberly Jackson-Bekemeier, a family physician with a personal story of managing Type 1 diabetes amidst the pandemic. Kimberly shares her journey of struggling with the d…

Fresh Produce Is an Increasingly Popular Prescription for Chronically Ill Patients

Fresh produce prescription programs are getting a boost in Montana as a way of helping people with chronic conditions such as diabetes and high blood pressure. The approach may be a model for other rural states to promote healthy eating in food deserts.

Breaking down barriers: How technology is improving diabetes management in underserved communities

Despite advancements in health information technology (HIT), the prevalence of diabetes in the United States continues to be high and is the seventh leading cause of death. Diabetes management in underserved communities has challenges concerning health…

California Picks Generic Drug Company Civica to Produce Low-Cost Insulin

Gov. Gavin Newsom, who blasted pharmaceutical companies for gouging Californians, is moving ahead with state-branded insulin. He’s also eyeing other generic drugs.

Why Does Insulin Cost So Much? Big Pharma Isn’t the Only Player Driving Prices

Big Pharma may be moving on from squeezing diabetes patients on insulin prices, but it’s the arbitrators that jack up prices for those who can least afford them.

Eli Lilly Slashed Insulin Prices. This Starts a Race to the Bottom.

Eli Lilly’s news that it plans to cut insulin costs for patients will help, not hinder, the recent efforts in California and by entrepreneurs such as Mark Cuban to offer lower-cost alternatives, drug pricing experts said.

Empowering Type 2 diabetes patients with innovative insulin management tools [PODCAST]

Subscribe to The Podcast by KevinMD. Catch up on old episodes! Our guest today is James Malone, an endocrinologist and health care executive with over 30 years of experience in the field of diabetes. James has seen firsthand the challenges that many pe…

Armed With Hashtags, These Activists Made Insulin Prices a Presidential Talking Point

Twitter has been a hotbed for the burgeoning insulin access movement and activism surrounding other medical conditions. For people with diabetes, the platform has helped propel concern about insulin prices into policy. Can it continue to win with hashtags?